logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9643957 B1

PDFFull Text
Expired
Date of Patent:
May. 09, 2017

Filed:

Dec. 10, 2013

Heterocyclic compounds having cholesterol 24-hydroxylase activity

Applicant:

Takeda Pharmaceutical Company Limited, Osaka, JP;

Inventors:

Tatsuki Koike, Kanagawa, JP;

Yuichi Kajita, Kanagawa, JP;

Masato Yoshikawa, Kanagawa, JP;

Shuhei Ikeda, Kanagawa, JP;

Hiromi Fukuda, Kanagawa, JP;

Assignee:

TAKEDA PHARMACEUTICAL COMPANY LIMITED, Osaka, JP;

Attorney:

Wenderoth, Lind & Ponack, L.L.P.

Primary Examiner:

Alexander R Pagano

Assistant Examiner:

Ebenezer O Sackey

Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 471/08 (2006.01); C07D 491/08 (2006.01); C07D 213/12 (2006.01); C07D 498/08 (2006.01); C07D 405/12 (2006.01); C07D 401/14 (2006.01); C07D 417/14 (2006.01); C07D 451/04 (2006.01); C07D 487/10 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 239/42 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 451/02 (2006.01); C07D 487/18 (2006.01); C07D 491/18 (2006.01); C07D 403/04 (2006.01); C07D 403/14 (2006.01); C07D 471/10 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); C07D 213/72 (2006.01); C07D 487/08 (2006.01); C12N 9/99 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); A61K 9/2018 (2013.01); A61K 9/4858 (2013.01); C07D 213/12 (2013.01); C07D 213/72 (2013.01); C07D 239/42 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 413/04 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 451/02 (2013.01); C07D 451/04 (2013.01); C07D 471/08 (2013.01); C07D 471/10 (2013.01); C07D 487/08 (2013.01); C07D 487/10 (2013.01); C07D 487/18 (2013.01); C07D 491/08 (2013.01); C07D 491/18 (2013.01); C07D 498/08 (2013.01); C12N 9/99 (2013.01);
Abstract

An object of the present invention is to provide a compound having a superior CH24H inhibitory action, which is useful as an agent for the prophylaxis or treatment of epilepsy, neurodegenerative disease and the like. The present invention relates to a compound represented by the formula: wherein each symbol is as defined in the specification, or a salt thereof.

Find Patent Forward Citations

Koike, Tatsuki. (2017). Heterocyclic compounds having cholesterol 24-hydroxylase activity (U.S. Patent No. 9643957). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9643957

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…